Loading...
Agilent Technologies, Inc.
0HAV.L•LSE
Healthcare
Medical - Pharmaceuticals
£118.006
£-1.44(-1.21%)
Agilent Technologies, Inc. (0HAV.L) Financial Performance & Statements
Review Agilent Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-4.73%
↓ 4.73%
Operating Income Growth
10.22%
↑ 10.22%
Net Income Growth
3.95%
↑ 3.95%
Operating Cash Flow Growth
-1.19%
↓ 1.19%
Operating Margin
23.24%
↑ 23.24%
Gross Margin
54.14%
↑ 54.14%
Net Profit Margin
19.27%
↑ 19.27%
ROE
20.95%
↑ 20.95%
ROIC
15.11%
↑ 15.11%
Agilent Technologies, Inc. (0HAV.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Agilent Technologies, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.68B | $1.70B | $1.58B | $1.57B |
| Cost of Revenue | $782.00M | $785.00M | $723.00M | $717.00M |
| Gross Profit | $901.00M | $916.00M | $855.00M | $856.00M |
| Gross Profit Ratio | $0.54 | $0.54 | $0.54 | $0.54 |
| R&D Expenses | $113.00M | $111.00M | $127.00M | $113.00M |
| SG&A Expenses | $410.00M | $397.00M | $395.00M | $380.00M |
| Operating Expenses | $523.00M | $508.00M | $522.00M | $493.00M |
| Total Costs & Expenses | $1.30B | $1.29B | $1.25B | $1.21B |
| Interest Income | $15.00M | $24.00M | $19.00M | $19.00M |
| Interest Expense | $28.00M | $32.00M | $22.00M | $20.00M |
| Depreciation & Amortization | $72.00M | $0.00 | $63.00M | $63.00M |
| EBITDA | $467.00M | $408.00M | $428.00M | $436.00M |
| EBITDA Ratio | $0.28 | $0.24 | $0.27 | $0.28 |
| Operating Income | $376.00M | $408.00M | $333.00M | $363.00M |
| Operating Income Ratio | $0.22 | $0.24 | $0.21 | $0.23 |
| Other Income/Expenses (Net) | -$9.00M | -$7.00M | $10.00M | $11.00M |
| Income Before Tax | $367.00M | $401.00M | $343.00M | $374.00M |
| Income Before Tax Ratio | $0.22 | $0.24 | $0.22 | $0.24 |
| Income Tax Expense | $49.00M | $50.00M | $61.00M | $66.00M |
| Net Income | $318.00M | $351.00M | $282.00M | $308.00M |
| Net Income Ratio | $0.19 | $0.21 | $0.18 | $0.20 |
| EPS | $1.12 | $1.21 | $0.97 | $1.05 |
| Diluted EPS | $1.11 | $1.21 | $0.97 | $1.05 |
| Weighted Avg Shares Outstanding | $285.00M | $290.00M | $290.00M | $293.00M |
| Weighted Avg Shares Outstanding (Diluted) | $287.00M | $291.00M | $291.00M | $293.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan